Cite
HARVARD Citation
Calafat, M. et al. (2022). Risk of Immunomediated Adverse Events and Loss of Response to Infliximab in Elderly Patients with Inflammatory Bowel Disease: A Cohort Study of the ENEIDA Registry. Journal of Crohn's and colitis. pp. 946-953. [Online].